Ashwin Ramachandran

Ashwin (Ash) Ramachandran is the founder and chief executive of Sapyen, an at-home male fertility testing company. Customers order a kit online, collect a sample at home and send it to a partner clinic or laboratory, with results in about three days. Sapyen says it operates in Australia, the US, the UK and parts of Europe and Southeast Asia.

Before Sapyen, he worked on intellectual property licensing and commercialisation at the University of Melbourne, on the campaign team at equity crowdfunding platform Birchal, and in professional services at Deloitte Digital and KPMG. He has also helped raise more than $215 million for healthcare and life sciences startups.

On The New Script with Frances Goh and Makenzie Thomas, he explained why male fertility is under-tested and how Sapyen's kits work.